Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Carcinoma”

1,348 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,348 results

Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Study completedNCT02288936
What this trial is testing

Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Spanish Oncology Genito-Urinary Group 98
Testing effectiveness (Phase 2)Looking for participantsNCT05806515
What this trial is testing

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8
SWOG Cancer Research Network 44
Testing effectiveness (Phase 2)Study completedNCT00087035
What this trial is testing

Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Testing effectiveness (Phase 2)Looking for participantsNCT06616597
What this trial is testing

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Testing effectiveness (Phase 2)Study completedNCT02153918
What this trial is testing

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

Who this might be right for
Prostate CancerProstatic NeoplasmsNeoplasms, Prostate
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT02023697
What this trial is testing

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Who this might be right for
Prostatic Neoplasms
Bayer 391
Large-scale testing (Phase 3)WithdrawnNCT00258466
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00002602
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,084
Not applicableActive Not RecruitingNCT06995053
What this trial is testing

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 91
Testing effectiveness (Phase 2)Study completedNCT01942837
What this trial is testing

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 67
Not applicableStudy completedNCT03961321
What this trial is testing

Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Amsterdam UMC, location VUmc 104
Testing effectiveness (Phase 2)Study completedNCT04288687
What this trial is testing

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 11
Testing effectiveness (Phase 2)Study completedNCT02326805
What this trial is testing

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
National Cancer Institute (NCI) 154
Testing effectiveness (Phase 2)Ended earlyNCT01313559
What this trial is testing

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerChemotherapy Naive Prostate CancerProstate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6
Testing effectiveness (Phase 2)Study completedNCT02077634
What this trial is testing

Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)

Who this might be right for
Prostate Cancer
Universität des Saarlandes 68
Testing effectiveness (Phase 2)Looking for participantsNCT07210086
What this trial is testing

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

Who this might be right for
Prostate Cancer
City of Hope Medical Center 50
Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Not applicableActive Not RecruitingNCT02339701
What this trial is testing

Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 68
Next Page